Found: 13
Select item for more details and to access through your institution.
Reversal of siRNA-mediated gene silencing in vivo.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 6, p. 509, doi. 10.1038/nbt.4136
- By:
- Publication type:
- Article
Rational design of cationic lipids for siRNA delivery.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 2, p. 172, doi. 10.1038/nbt.1602
- By:
- Publication type:
- Article
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia.
- Published in:
- Nature Medicine, 2015, v. 21, n. 5, p. 492, doi. 10.1038/nm.3847
- By:
- Publication type:
- Article
Unique Gene-Silencing and Structural Properties of 2′-Fluoro-Modified siRNAs.
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 10, p. 2332, doi. 10.1002/ange.201006519
- By:
- Publication type:
- Article
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 8, p. 1570, doi. 10.1038/mt.2013.124
- By:
- Publication type:
- Article
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2186, doi. 10.1038/mt.2011.190
- By:
- Publication type:
- Article
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 7, p. 1357, doi. 10.1038/mt.2010.85
- By:
- Publication type:
- Article
Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 5, p. 872, doi. 10.1038/mt.2009.36
- By:
- Publication type:
- Article
Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates.
- Published in:
- Nucleic Acids Research, 2024, v. 52, n. 10, p. 5423, doi. 10.1093/nar/gkae350
- By:
- Publication type:
- Article
siRNAs containing 2′-fluorinated Northern-methanocarbacyclic (2′-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2′-F-NMC NTPs.
- Published in:
- Nucleic Acids Research, 2021, v. 49, n. 5, p. 2435, doi. 10.1093/nar/gkab050
- By:
- Publication type:
- Article
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates.
- Published in:
- Nucleic Acids Research, 2020, v. 48, n. 21, p. 11827, doi. 10.1093/nar/gkaa670
- By:
- Publication type:
- Article
Reactivity of Resident Immunocytes in Normal and Prepsoriatic Skin Using an Ex Vivo Skin-Explant Model System.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2003, v. 127, n. 3, p. 289, doi. 10.5858/2003-127-0289-roriin
- By:
- Publication type:
- Article
Unique Gene-Silencing and Structural Properties of 2′-Fluoro-Modified siRNAs.
- Published in:
- Angewandte Chemie International Edition, 2011, v. 50, n. 10, p. 2284, doi. 10.1002/anie.201006519
- By:
- Publication type:
- Article